Related Experiment Video
Updated: Jan 11, 2026
Precision Implementation of Minimal Erythema Dose MED Testing to Assess Individual Variation in Human Inflammatory Response
Published on: October 3, 2019
Mediterranean Diet Reduces Inflammation in Adults: A Systematic Review and Meta-analysis of Randomized Controlled
Mahdi Keshani1, Sahar Rafiee1, Hajar Heidari1
1Nutrition and Food Security Research Center and Department of Community Nutrition, School of Nutrition and Food Science, Isfahan University of Medical Sciences, Isfahan 8174673482, Iran.
Context:
Inflammation and oxidative stress play pivotal roles in the pathogenesis of chronic diseases, such as cardiovascular disease (CVD), diabetes, and neurodegenerative disorders. The Mediterranean diet (MD) has shown promise in mitigating these factors, but results across studies have been inconsistent.
Objective:
Given the lack of clear evidence regarding the effects of an MD on inflammatory and oxidative stress biomarkers, we carried out a systematic review and meta-analysis to assess its true impact.
Data Sources:
A systematic review and meta-analysis was conducted on randomized controlled trials (RCTs) to evaluate the effects of the MD on biomarkers of inflammation and oxidative stress, and a comprehensive search across PubMed, Web of Science, and Scopus, and a hand-search up to July 2024 was performed.
Data Extraction:
After removing duplicates and screening titles and abstracts, eligible records were retrieved. For unavailable full texts, authors were contacted, and unresponsive cases were excluded. Data extracted included author, year, country, group sizes, mean age, health conditions, intervention details and duration, outcomes, and statistical measures (means, SDs, and changes).
Data Analysis:
33 RCTs involving 3476 participants were included. Significant reductions were observed for high-sensitivity C-reactive protein (hs-CRP), interleukin (IL)-6, and IL-17 in the MD group in comparison to a control diet. However, no significant effects were noted for CRP, IL-10, tumor necrosis factor-alpha, or total antioxidant capacity. Subgroup analyses revealed stronger effects for specific age groups and intervention durations. In participants aged <60 years, with intervention durations <12 weeks, and in individuals with CVD, IL-6 was reduced significantly following the MD regimen.
Conclusion:
The MD can significantly improve certain inflammation biomarkers, particularly hs-CRP, IL-6, and IL-17, supporting its potential role in reducing inflammation-related risks. However, further high-quality studies will be essential to confirm these findings.
Systematic Review Registration:
PROSPERO no. CRD42024613719.
More Related Videos
09:04DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
Published on: February 27, 2014
07:22Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
Related Concept Videos
01:26Atherosclerosis III: Management
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
01:28Inflammatory Response
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
01:30Coronary Artery Disease I: Introduction
01:38Inflammation
01:21Rheumatic Heart Disease III: Medical Management